US2020360876A1PendingUtilityA1
Microfluidic devices
Est. expiryMay 11, 2026(expired)· nominal 20-yr term from priority
B01J 19/0093B01F 23/41B01F 33/3011C12Q 1/686G01N 2035/00237G01N 2035/00326B01L 2200/0647C12N 15/1086B01L 2200/10B01L 2300/0861B01L 2200/0673C12Q 1/00B01L 2400/0424G01N 2021/0346B01L 3/502746G01N 2201/024B01L 3/502715C12Q 1/6874B01L 2300/0867G01N 21/64Y10T137/87619B01L 2300/0816B01L 2300/165C12Q 1/6837B01L 2300/0636C12Q 2565/629C12Q 1/6806B01L 2300/0864B03C 5/005B01L 2400/086B01L 7/525B01L 9/527C12Q 1/6855Y10T137/87571B01L 3/502784B01L 2400/0415G01N 21/05G01N 35/08G01N 15/147B01L 2200/0636C12Q 2565/628Y10T137/87652C12Q 1/6844C12N 15/1068B01L 3/565B01L 2400/0487B01L 2200/027G01N 27/3275C12Q 1/6869B03C 5/026C12Q 1/6846B01F 3/0807B01F 13/0062
77
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention provides novel microfluidic substrates and methods that are useful for performing biological, chemical and diagnostic assays. The substrates can include a plurality of electrically addressable, channel bearing fluidic modules integrally arranged such that a continuous channel is provided for flow of immiscible fluids.
Claims
exact text as granted — not AI-modified1 - 20 . (canceled)
21 . A method for analyzing an amplification reaction product, the method comprising:
providing a plurality of aqueous droplets separated by an oil in a reservoir of a fluidic device, wherein one or more of the droplets comprise nucleic acid molecules and reagents for an amplification reaction; conducting the nucleic acid amplification reaction simultaneously in the droplets while the droplets are in the reservoir; and detecting amplification product in the droplets via imaging.
22 . The method of claim 21 , wherein the imaging provides for the simultaneous detection of contents of the droplets in parallel.
23 . The method of claim 21 , wherein the droplets are spatially distributed in a two-dimensional sheet during imaging.
24 . The method of claim 23 , wherein the droplets are spatially distributed in the two-dimensional sheet within a microscopic field-of-view.
25 . The method of claim 21 , wherein the imaging comprises fluorescence imaging.
26 . The method of claim 21 , wherein the amplification reaction is a polymerase chain reaction (PCR).
27 . The method of claim 21 , wherein the fluidic device comprises a chip, the amplification reaction comprises PCR, and the conducting step comprises performing PCR in the droplets on the chip.
28 . The method of claim 21 , wherein the during the imaging, an optical signal indicates presence of a nucleic acid amplification product in at least one of the droplets.
29 . The method of claim 21 , wherein the droplets and the oil have different densities.
30 . The method of claim 21 , wherein the oil is a fluorinated oil.
31 . The method of claim 21 , wherein the oil comprises a fluorosurfactant.
32 . The method of claim 21 , further comprising, prior to conducing the amplification reaction, forming the plurality of the droplets using at least one channel of the fluidic device.
33 . The method of claim 32 , further comprising the step of merging the reagents into the droplets to provide the droplets that comprise the nucleic acid molecules and the reagents.
34 . The method of claim 32 , wherein the reservoir is in fluid communication with the channel.
35 . The method of claim 32 , wherein the fluidic device comprises a microfabricated chip that includes the reservoir and the droplet formation channel.Join the waitlist — get patent alerts
Track US2020360876A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.